{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:15:26Z","timestamp":1790421326164,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T00:00:00Z","timestamp":1554854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T00:00:00Z","timestamp":1554854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Metformin was shown to sensitize multidrug resistant breast cancer cells; however, the mechanisms involved in this capacity need to be clarified. We investigated oxidative stress and inflammatory-related pathways during the induction of doxorubicin resistance in MCF-7 and MDA-MB-231 human breast cancer cells (DOX-res group), and evaluated metformin-induced cellular responses that resulted in the prevention of doxorubicin resistance (Met-DOX group). Microarray analysis demonstrated that DOX-res changed the expression of genes involved in oxidative stress (OS) and the TGF- \u03b21 pathway. The DOX-res group presented increased thiols and reduced lipoperoxidation, increased levels of nitric oxide, nuclear NF-kB and Nrf2, and reduced nuclear p53 labelling. Analysis of the TGF-\u03b21 signaling pathway by RT-PCR array showed that DOX-res developed adaptive responses, such as resistance against apoptosis and OS. Metformin treatment modified gene expression related to OS and the IFN-\u03b1 signaling pathway. The Met-DOX group was more sensitive to DOX-induced OS, presented lower levels of nitric oxide, nuclear NF-kB and Nrf2, and increased nuclear p53. Analysis of the IFN-\u03b1 signaling pathway showed that Met-DOX presented more sensitivity to apoptosis and OS. Our findings indicate that metformin is a promising tool in the prevention of chemoresistance in patients with breast cancer submitted to doxorubicin-based treatments.<\/jats:p>","DOI":"10.1038\/s41598-019-42357-w","type":"journal-article","created":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T06:18:48Z","timestamp":1554877128000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["Metformin prevention of doxorubicin resistance in MCF-7 and MDA-MB-231 involves oxidative stress generation and modulation of cell adaptation genes"],"prefix":"10.1038","volume":"9","author":[{"given":"Poliana Camila","family":"Marinello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Panis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thamara Nishida Xavier","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Binato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Abdelhay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Alves","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Luiz","family":"Mencalha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e1lia Medeiros Dias","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Cabral","family":"Luiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubens","family":"Cecchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra Louren\u00e7o","family":"Cecchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,10]]},"reference":[{"issue":"3","key":"42357_CR1","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00280-009-1182-7","volume":"66","author":"L Hu","year":"2010","unstructured":"Hu, L., Miao, W., Loignon, M., Kandouz, M. & Batist, G. Putative chemopreventive molecules can increase Nrf2-regulated cell defense in some human cancer cell lines, resulting in resistance to common cytotoxic therapies. Cancer Chemother Pharmacol 66(3), 467\u201374 (2010).","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"42357_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10549-011-1693-x","volume":"133","author":"C Panis","year":"2012","unstructured":"Panis, C. et al. Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy. Breast Cancer Res Treat. 133(1), 89\u201397 (2012).","journal-title":"Breast Cancer Res Treat."},{"key":"42357_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.bihy.2009.01.005","volume":"2","author":"M Zhang","year":"2009","unstructured":"Zhang, M., Wang, J., Zhang, L. & Zhou, S. EGFR-Nrf2 pathway plays a role in cancer cell\u2019s chemoresistance. Bioscience Hypotheses 2, 261\u2013263 (2009).","journal-title":"Bioscience Hypotheses"},{"key":"42357_CR4","doi-asserted-by":"crossref","unstructured":"Dalmases, A. et al. Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-\u043aB target genes in human breast cancer. Oncotarget, 5 (2013).","DOI":"10.18632\/oncotarget.1556"},{"key":"42357_CR5","doi-asserted-by":"publisher","first-page":"e38347","DOI":"10.1371\/journal.pone.0038347","volume":"7","author":"J Ingles-Esteve","year":"2012","unstructured":"Ingles-Esteve, J. et al. Inhibition of specific NF-kappaB activity contributes to the tumor suppressor function of 14-3-3sigma in breast cancer. PLoS One 7, e38347 (2012).","journal-title":"PLoS One"},{"key":"42357_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1530\/JME-12-0007","volume":"48","author":"RJ Dowling","year":"2012","unstructured":"Dowling, R. J., Niraula, S., Stambolic, V. & Goodwin, P. J. Metformin in cancer: translational challenges. J Mol Endocrinol 48, 31\u201343 (2012).","journal-title":"J Mol Endocrinol"},{"key":"42357_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11010-013-1845-x","volume":"386","author":"C Qu","year":"2014","unstructured":"Qu, C. et al. Metformin reverses multidrug resistance and epithelial\u2013 mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells. Mol Cell Biochem 386, 63\u201371 (2014).","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"42357_CR8","first-page":"232","volume":"12","author":"A Rimessi","year":"2013","unstructured":"Rimessi, A., Patergnani, S., Ioannidi, E. & Pinton, P. Chemoresistance and Cancer-Related Inflammation: Two Hallmarks of Cancer Connected by an Atypical Link, PKC\u03b6. Front Oncol. 12(3), 232 (2013).","journal-title":"Front Oncol."},{"key":"42357_CR9","first-page":"5141","volume":"47","author":"CR Fairchild","year":"1987","unstructured":"Fairchild, C. R. et al. Isolation of Amplified and Overexpressed DNA Sequences from Adriamycin resistant Human Breast Cancer Cells. Cancer Research 47, 5141\u20135148 (1987).","journal-title":"Cancer Research"},{"key":"42357_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation cytotoxic assays. J Immunol Methods 65, 55\u201363 (1983).","journal-title":"J Immunol Methods"},{"key":"42357_CR11","first-page":"737","volume":"33","author":"C Panis","year":"2013","unstructured":"Panis, C., Herrera, A. C., Victorino, V. J., Aranome, A. M. F. & Cecchini, R. Screening of circulating TGF-\u03b2 level and its clinicopathological significance in human breast cancer. Anticancer Research 33, 737\u201342 (2013).","journal-title":"Anticancer Research"},{"key":"42357_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0891-5849(91)90002-K","volume":"10","author":"B Gonzalez-Flecha","year":"1991","unstructured":"Gonzalez-Flecha, B., Llesuy, S. & Boveris, A. Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver, and muscle. Free Radic Biol Med 10, 93\u2013100 (1991).","journal-title":"Free Radic Biol Med"},{"key":"42357_CR13","doi-asserted-by":"crossref","first-page":"23106","DOI":"10.1016\/S0021-9258(19)49432-5","volume":"268","author":"K Kikuchi","year":"1993","unstructured":"Kikuchi, K., Nagano, T., Hayakawa, H., Hirata, Y. & Hirobe, M. Real time measurement of nitric oxide produced ex vivo by luminol-H202 chemiluminescence method. J. Biol. Chem 268, 23106\u201323110 (1993).","journal-title":"J. Biol. Chem"},{"key":"42357_CR14","doi-asserted-by":"publisher","first-page":"10367","DOI":"10.3390\/molecules180910367","volume":"18","author":"N Abu","year":"2013","unstructured":"Abu, N., Akhtar, M. N., Ho, W. Y., Yeap, S. K. & Alithen, N. B. 3-Bromo-1-Hydroxy-9,10-Anthraquinone (BHAQ) Inhibits Growth and Migration of the Human Breast Cancer Cell Lines MCF-7 and MDA-MB231. Molecules 18, 10367\u201310377 (2013).","journal-title":"Molecules"},{"key":"42357_CR15","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1002\/hep.25549","volume":"55","author":"Q Chen","year":"2012","unstructured":"Chen, Q. et al. Amplified in Breast Cancer 1 Enhances Human Cholangiocarcinoma Growth and Chemoresistance by Simultaneous Activation of Akt and Nrf2 Pathways. Hepatology 55, 1820\u20131829 (2012).","journal-title":"Hepatology"},{"key":"42357_CR16","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1126\/science.1121513","volume":"311","author":"ZH Wu","year":"2006","unstructured":"Wu, Z. H., Shi, Y., Tibbetts, R. S. & Miyamoto, S. Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli. Science 311, 1141\u20131146 (2006).","journal-title":"Science"},{"key":"42357_CR17","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.4161\/cc.6.18.4721","volume":"6","author":"MA Tapia","year":"2007","unstructured":"Tapia, M. A. et al. Inhibition of the canonical IKK\/NF kappa B pathway sensitizes human cancer cells to doxorubicin. Cell Cycle 6, 2284\u20132292 (2007).","journal-title":"Cell Cycle"},{"key":"42357_CR18","first-page":"167","volume":"1805","author":"F Li","year":"2010","unstructured":"Li, F. & Sethi, G. Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy. Biochim Biophys Acta. 1805, 167\u201380 (2010).","journal-title":"Biochim Biophys Acta."},{"key":"42357_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1172\/JCI11830","volume":"107","author":"PP Tak","year":"2001","unstructured":"Tak, P. P. & Firestein, G. S. NF-\u03baB: a key role in inflammatory diseases. J Clin Invest 107, 7\u201311 (2001).","journal-title":"J Clin Invest"},{"key":"42357_CR20","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1158\/1541-7786.MCR-12-0124","volume":"10","author":"CH Switzer","year":"2012","unstructured":"Switzer, C. H. et al. S-Nitrosylation of EGFR and Src activates an oncogenic signaling network in human basal-like breast cancer. Mol Cancer Res 10, 1203\u20131215 (2012).","journal-title":"Mol Cancer Res"},{"key":"42357_CR21","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1006\/bbrc.1998.9719","volume":"252","author":"J Kroll","year":"1998","unstructured":"Kroll, J. & Waltenberger, J. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem Biophys Res Commun 252, 743\u20136 (1998).","journal-title":"Biochem Biophys Res Commun"},{"key":"42357_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1749-6632.2012.06734.x","volume":"127","author":"AY Ali","year":"2012","unstructured":"Ali, A. Y. et al. Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum. Ann N Y Acad Sci 127, 58\u201367 (2012).","journal-title":"Ann N Y Acad Sci"},{"key":"42357_CR23","doi-asserted-by":"crossref","unstructured":"Masciarelli, S. et al. Gain-of-function mutante p53 downregulates miR-223 contributing to chemoresistance of culture tumor cells. Oncogene [Epub ahead of print] (2013).","DOI":"10.1038\/onc.2013.106"},{"key":"42357_CR24","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1074\/jbc.M111.314765","volume":"287","author":"MG Woo","year":"2012","unstructured":"Woo, M. G., Xue, K., Liu, J., McBride, H. & Tsang, B. K. Calpain-mediated processing of p53-associated parkin-like cytoplasmic protein (PARC) affects chemosensitivity of human ovarian cancer cells by promoting p53 subcellular trafficking. J. Biol. Chem 287, 3963\u20133975 (2012).","journal-title":"J. Biol. Chem"},{"key":"42357_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/onc.2009.300","volume":"29","author":"MR Abedini","year":"2010","unstructured":"Abedini, M. R., Muller, E. J., Bergeron, R., Gray, D. A. & Tsang, B. K. Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein. Oncogene 29, 11\u201325 (2010).","journal-title":"Oncogene"},{"key":"42357_CR26","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1074\/jbc.M109.064212","volume":"285","author":"ST Lim","year":"2010","unstructured":"Lim, S. T. et al. Pyk2 inhibition of p53 as an adaptive and intrinsic mechanism facilitating cell proliferation and survival. J Biol Chem 285, 1743\u201353 (2010).","journal-title":"J Biol Chem"},{"key":"42357_CR27","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.freeradbiomed.2015.11.024","volume":"90","author":"F Paredes","year":"2016","unstructured":"Paredes, F. et al. HERPUD1 protects against oxidative stress-induced apoptosis through downregulation of the inositol 1,4,5-trisphosphate receptor. Free Radic Biol Med 90, 206\u201318 (2016).","journal-title":"Free Radic Biol Med"},{"key":"42357_CR28","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.febslet.2015.01.026","volume":"589","author":"DV Ho","year":"2015","unstructured":"Ho, D. V. & Chan, J. Y. Induction of Herpud1 expression by ER stress is regulated by Nrf1. FEBS Lett 589, 615\u201320 (2015).","journal-title":"FEBS Lett"},{"key":"42357_CR29","doi-asserted-by":"crossref","first-page":"73593","DOI":"10.18632\/oncotarget.12435","volume":"7","author":"C Zhang","year":"2016","unstructured":"Zhang, C. et al. NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA\/ROCK pathway signal transduction. Oncotarget 7, 73593\u201373606 (2016).","journal-title":"Oncotarget"},{"key":"42357_CR30","first-page":"25","volume":"22","author":"A Bellizzi","year":"2008","unstructured":"Bellizzi, A. et al. RhoA protein expression in primary breast cancers and matched lymphocytes is associated with progression of the disease. Int J Mol Med 22, 25\u201331 (2008).","journal-title":"Int J Mol Med"},{"key":"42357_CR31","doi-asserted-by":"publisher","first-page":"e28579","DOI":"10.4161\/sgtp.28579","volume":"5","author":"GA Hobbs","year":"2014","unstructured":"Hobbs, G. A., Zhou, B., Cox, A. D. & Campbell, S. L. Rho GTPases, oxidation, and cell redox control. Small GTPases. 5, e28579 (2014).","journal-title":"Small GTPases."},{"key":"42357_CR32","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.1158\/0008-5472.CAN-06-2644","volume":"67","author":"GW Small","year":"2007","unstructured":"Small, G. W., Shi, Y. Y., Higgins, L. S. & Orlowski, R. Z. Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance. Cancer Res 67, 4459\u201366 (2007).","journal-title":"Cancer Res"},{"key":"42357_CR33","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/35085597","volume":"412","author":"C Wang","year":"2001","unstructured":"Wang, C. et al. TAK1 is an ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346\u201351 (2001).","journal-title":"Nature"},{"key":"42357_CR34","volume":"7","author":"Y Hu","year":"2016","unstructured":"Hu, Y. et al. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer. Cell Death Dis 7, e22912016 (2016).","journal-title":"Cell Death Dis"},{"key":"42357_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-014-0428-4","volume":"16","author":"MJ Duffy","year":"2014","unstructured":"Duffy, M. J., McGowan, P. M., Harbeck, N., Thomssen, C. & Schmitt, M. uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies. Breast Cancer Res 16, 428 (2014).","journal-title":"Breast Cancer Res"},{"key":"42357_CR36","doi-asserted-by":"publisher","first-page":"e66343","DOI":"10.1371\/journal.pone.0066343","volume":"8","author":"V Cheung","year":"2013","unstructured":"Cheung, V., Bouralexis, S. & Gillespie, M. T. PTHrP Overexpression Increases Sensitivity of Breast Cancer Cells to Apo2L\/TRAIL. PLoS One 8, e66343 (2013).","journal-title":"PLoS One"},{"key":"42357_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3297-2","volume":"17","author":"KMK Mark","year":"2017","unstructured":"Mark, K. M. K., Frederick, S. V., Ung, M. H. & Qian, F. Chao Cheng. The E2F4 prognostic signature predicts pathological response to neoadjuvant chemotherapy in breast cancer patients. BMC Cancer. 17, 306 (2017).","journal-title":"BMC Cancer."},{"key":"42357_CR38","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.humpath.2018.01.004","volume":"74","author":"YH Li","year":"2018","unstructured":"Li, Y. H. et al. The value of detection of S100A8 and ASAH1 in predicting the chemotherapy response for breast cancer patients. Hum Pathol 74, 156\u2013163 (2018).","journal-title":"Hum Pathol"},{"key":"42357_CR39","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/sj.bjc.6605486","volume":"102","author":"J Chen","year":"2010","unstructured":"Chen, J., Imanaka, N., Chen, J. & Griffin, J. D. Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion. Br J Cancer 102, 351\u2013360 (2010).","journal-title":"Br J Cancer"},{"key":"42357_CR40","first-page":"4363","volume":"18","author":"AU Gnirke","year":"1998","unstructured":"Gnirke, A. U. & Weidle, U. H. Investigation of prevalence and regulation of expression of progression associated protein (PAP). Anticancer Res 18, 4363\u20134369 (1998).","journal-title":"Anticancer Res"},{"key":"42357_CR41","first-page":"953","volume":"18","author":"A Chhabra","year":"2007","unstructured":"Chhabra, A., Fernando, H., Watkins, G., Mansel, R. E. & Jiang, W. G. Expression of transcription factor CREB1 in human breast cancer and its correlation with prognosis. Oncol Rep 18, 953\u2013958 (2007).","journal-title":"Oncol Rep"},{"key":"42357_CR42","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1002\/jcb.24533","volume":"114","author":"R Shi","year":"2013","unstructured":"Shi, R. et al. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7\/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation. J Cell Biochem 114, 1890\u2013900 (2013).","journal-title":"J Cell Biochem"},{"issue":"10","key":"42357_CR43","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1002\/cam4.833","volume":"5","author":"JG Habib","year":"2016","unstructured":"Habib, J. G. & O\u2019Shaughnessy, J. \u00c1. The hedgehog pathway in triple-negative breast cancer. Cancer Med. 5(10), 2989\u20133006 (2016).","journal-title":"Cancer Med."},{"key":"42357_CR44","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/15384047.2015.1016662","volume":"16","author":"ZH Liu","year":"2015","unstructured":"Liu, Z. H., Dai, X. M. & Du, B. Hes1: a key role in stemness, metastasis and multidrug resistance. Cancer Biol Ther 16, 353\u20139 (2015).","journal-title":"Cancer Biol Ther"},{"key":"42357_CR45","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1158\/0008-5472.CAN-11-3055","volume":"73","author":"S Kazerounian","year":"2013","unstructured":"Kazerounian, S. et al. RhoB differentially controls Akt function in tumor cells and stromal endothelial cells during breast tumorigenesis. Cancer Res 73, 50\u201361 (2013).","journal-title":"Cancer Res"},{"key":"42357_CR46","doi-asserted-by":"crossref","first-page":"74931","DOI":"10.18632\/oncotarget.11647","volume":"7","author":"D Nettersheim","year":"2016","unstructured":"Nettersheim, D. et al. A signaling cascade including ARID1A, GADD45B and DUSP1 induces apoptosis and affects the cell cycle of germ cell cancers after romidepsin treatment. Oncotarget 7, 74931\u201374946 (2016).","journal-title":"Oncotarget"},{"key":"42357_CR47","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.tranon.2018.06.001","volume":"11","author":"MS Hasim","year":"2018","unstructured":"Hasim, M. S., Nessim, C., Villeneuve, P. J., Vanderhyden, B. C. & Dimitroulakos, J. Activating Transcription Factor 3 as a Novel Regulator of Chemotherapy Response in Breast Cancer. Translational Oncology 11, 988\u2013998 (2018).","journal-title":"Translational Oncology"},{"key":"42357_CR48","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.4161\/cbt.29693","volume":"15","author":"E Tarasewicz","year":"2014","unstructured":"Tarasewicz, E. et al. CDK4 inhibition and doxorubicin mediate breast cancer cell apoptosis through Smad3 and survivin. Cancer Biol Ther 15, 1301\u201311 (2014).","journal-title":"Cancer Biol Ther"},{"key":"42357_CR49","doi-asserted-by":"publisher","unstructured":"Wu, Y., Vadgama, J. V. Androgen receptor as a potential target for treatment of breast cancer. Int J Cancer Res Mol Mech, 3, https:\/\/doi.org\/10.16966\/2381-3318.129 (2017).","DOI":"10.16966\/2381-3318.129"},{"key":"42357_CR50","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.canlet.2017.09.030","volume":"412","author":"H Xu","year":"2018","unstructured":"Xu, H. et al. CXCR2 promotes breast cancer metastasis and chemoresistance via suppression of AKT1 and activation of COX2. Cancer Lett 412, 69\u201380 (2018).","journal-title":"Cancer Lett"},{"key":"42357_CR51","first-page":"6929","volume":"14","author":"X Dai","year":"2017","unstructured":"Dai, X., Fang, M., Li, S., Yan, Y., Zhong, Y. & Du, B. miR-21 is involved in transforming growth factor \u03b21-induced chemoresistance and invasion by targeting PTEN in breast cancer. Oncol Lett 14, 6929\u2013s6936 (2017).","journal-title":"Oncol Lett"},{"key":"42357_CR52","first-page":"737","volume":"33","author":"C Panis","year":"2013","unstructured":"Panis, C., Herrera, A. C., Victorino, V. J., Aranome, A. M. & Cecchini, R. Screening of circulating TGF-\u03b2 levels and its clinicopathological significance in human breast cancer. Anticancer Res 33, 737\u201342 (2013).","journal-title":"Anticancer Res"},{"key":"42357_CR53","doi-asserted-by":"publisher","unstructured":"Krstic, J., Trivanovic, D., Mojsilovic, S. & Santibanez, J. F. Transforming growth factor-beta and oxidative stress interplay: implications in tumorigenesis and cancer progression. Dig Oxid Med Cell Longev, https:\/\/doi.org\/10.1155\/2015\/654594 (2015).","DOI":"10.1155\/2015\/654594"},{"key":"42357_CR54","doi-asserted-by":"publisher","unstructured":"Pires, B. R. B., Binato, R., Ferreira, G. M., Cecchini, R., Panis, C. & Abdelhay, E. NF-kappaB Regulates Redox Status in Breast Cancer Subtypes. Genes (Basel) https:\/\/doi.org\/10.3390\/genes9070320 (2018).","DOI":"10.3390\/genes9070320"},{"key":"42357_CR55","doi-asserted-by":"crossref","unstructured":"Kevin, Lu. et al. NRF2 induction supporting breast cancer cell survival is enabled by oxidative stressinduced DPP3-KEAP1 interaction. Cancer Res 77, 2881\u20132892 (2017).","DOI":"10.1158\/0008-5472.CAN-16-2204"},{"key":"42357_CR56","doi-asserted-by":"crossref","unstructured":"Pflaum, J., Schlosser, S. & M\u00fcller, M. p53 Family and Cellular Stress Responses in Cancer. Front Oncol 4, 285 (2014).","DOI":"10.3389\/fonc.2014.00285"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42357-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42357-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42357-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T03:33:50Z","timestamp":1671248030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42357-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,10]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["42357"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-42357-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,10]]},"assertion":[{"value":"24 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5864"}}